I'm somewhat unclear why an inclusion criterion was 'receiving a coronary stent' when early percutaneous coronary artery angioplasty did not always include stenting? Given that the included studies date back only to 2011 (though the inclusion was from database inception to April, 2018), this is not necessarily an issue regarding validity of the review. However, if earlier studies are identified in other databases, it might be problematic. Results. Table 1 . The acronym NOS needs to be identified in the legend. I was somewhat surprised to read that nearly 1300 articles were reviewed. Yet, the PRISMA diagram appears to indicate that nearly 1300 abstracts were reviewed then 153 full articles were reviewed. Please clarify this inconsistency. Discussion. Pg 7. Ln 18. '…few reviews have been conducted…(in PCI patients). I did not find these reviews cited in the reference list. If reviews have been undertaken, when were they done, what was found, and why is another systematic review needed? Also, these should be cited in the introduction. The information regarding sub-analysis for when depression was measured is very important and should be included in the results section. I was somewhat surprised that there was no discussion about how depression has been measured (beyond it being a dichotomous variable). The HADS, for example, is merely a screening tool and not a clinical diagnostic measure for depression.
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GENERAL COMMENTS
The purpose of this review was to identify whether depression in PCI patients is associated with higher risk of adverse events. The emphasis on prognosis is of significant interest, necessary of establishing findings in this area. With preceding studies having mixed results, this is both a timely and necessary review. Overall the systematic review and meta-analysis is well written, clear and concise.
The strengths of this review are that the quality of the studies were of a high standard and that it was well referenced to the topic. However, the quality assessment 'NOS' is only reported as a single rating 1-9 with no description or justification for the ratingmore information is necessary. Further delineation of whether the review was assessing 'depression' or depressive symptoms' or both, which may be viewed as problematic, and justification for this would assist the quality of the review and is necessary to substantiate the outcomes of the review. 
This is generally a well-written manuscript.
In Table 1 , add reference numbers after each study to make them easier to find in the list of references.
In Table 2 , rather write the risk ratio and 95% CI in the form "1.51 (1.26, 1.81)". If not, at least change the order of the columns to put the risk ratio before the lower CI limit.
In Figure 2 Consider putting the studies in the same order in all the tables and figures.
VERSION 1 -AUTHOR RESPONSE
Reviewer 1: Reviewer Name: Kathryn King-Shier
To Reviewer 1:
Comment: I believe the first sentence could be eliminated as the following sentence is more compelling. Reply:
The first sentence has been removed according to the suggestion. Reply: Thank you for your comments. It is most likely that depression may also associate with post-ACS or post-CABG, not only in post-PCI. While depression has been associated with adverse events among different groups of patients, a lot of problems remain to study further. For one thing, PCI was found to contribute to higher risk of developing depressive symptoms during hospitalization. Mental status of PCI patients may be an important factor for recovery. For another, considering levels of depression tend to change over time, questions remain about when to assess depression. In addition, it is not clear whether the indication of PCI (MI, ACS, or SA) and follow-up period have significant impact on the predictive effect of depression. Therefore, we believe this article has a certain value for academic studies in relevant domains. Necessary discussion has been added in the Introduction part. Figure 1) Comment: Pg 7. Ln 18. '…few reviews have been conducted…(in PCI patients). I did not find these reviews cited in the reference list. If reviews have been undertaken, when were they done, what was found, and why is another systematic review needed? Also, these should be cited in the introduction. Reply: As far as we know, no previous systematic review or meta-analysis has been performed about the effect of depression in PCI patients. We are very sorry for our incorrect writing of this sentence. The statement has been corrected as "little is known about the impact of depression on prognosis in PCI patients".
Comment:
The information regarding sub-analysis for when depression was measured is very important and should be included in the results section. Reply: Thank you for the suggestion. In accordance with the reviewer concerns, we have added a brief introduction about when depression was measured in the results section (Page 5 Lines 50-58):" Of the identified studies five measured depression only once, varying from before the procedure during hospitalization to six months post PCI. Three of the studies assessed depression twice. The research by Yu et al. (2017) measured depression at baseline during hospitalization and one month after discharge. Wang et al. (2013) and Li et al. (2012) assessed depression both before and after the PCI. These two studies suggested depression was present in nearly 40% of the postoperative patients, increasing more than 10 percentage points than that before the operation."
Comment: I was somewhat surprised that there was no discussion about how depression has been measured (beyond it being a dichotomous variable). The HADS, for example, is merely a screening tool and not a clinical diagnostic measure for depression. Reply:
We thank the reviewer for this constructive critique. We have added the discussion about depression was measured in our revised manuscript in the discussion part (Page 7 Line 51-Page 8 Line 10)," While a positive correlation between depression symptoms and adverse cardiac outcomes was found in our research, careful consideration should be given to different methods of depression assessment. In the majority of included articles, depression was defined based on scores of a self-report screening instrument, for example, the Hospital Anxiety and Depression Scale (HADS), rather than structured or semi structured diagnostic interviews. Although several screening instruments have been showed high sensitivity or specificity for CAD patients and were used more often by physicians in general hospitals to assess depression, no consensus has yet been reached on the optimal screening tool for use in identifying depression in patients with coronary heart disease. Since the word 'depression' may include different meanings ranging from transient negative emotions through to serious clinical symptoms, more cautious needs to be taken when investigating the prognostic value of depression in further studies."
We feel great thanks for your professional review work on our article
Reviewer 2: Reviewer Name: Chantal Ski
To Reviewer 2:
Comment:
The purpose of this review was to identify whether depression in PCI patients is associated with higher risk of adverse events. The emphasis on prognosis is of significant interest, necessary of establishing findings in this area. With preceding studies having mixed results, this is both a timely and necessary review. Overall the systematic review and meta-analysis is well written, clear and concise. Reply: Thank you for your very positive overall evaluation.
The quality assessment 'NOS' is only reported as a single rating 1-9 with no description or justification for the rating -more information is necessary. Reply: Thank you for pointing that out. We have provided the table of quality assessment with score of each item based on the Newcastle-Ottawa Scale. (see Supplementary Table S1) Comment: Delineation of whether the review was assessing 'depression' or depressive symptoms' or both, which may be viewed as problematic, and justification for this would assist the quality of the review and is necessary to substantiate the outcomes of the review. Comment: This is generally a well-written manuscript. Reply: Thank you for the very positive evaluation of our manuscript.
Other comments:
Reply: Reference numbers have been added after each study. (see revised Table 1) Comment:
In Table 2 , rather write the risk ratio and 95% CI in the form "1.51 (1.26, 1.81)". If not, at least change the order of the columns to put the risk ratio before the lower CI limit. Reply: Thank you for this suggestion for improvement. The original table was streamlined. (see revised Table  2 
GENERAL COMMENTS
The responses to the previous review are reasonable.
